Literature DB >> 33901563

Outcomes of curative-intent radiotherapy in non-small cell lung cancer (NSCLC) patients with chronic obstructive pulmonary disease (COPD) and interstitial lung disease (ILD).

Celion Tang1, Hitesh Mistry2, Neil Bayman3, Clara Chan3, David Cobben4, Corinne Faivre-Finn4, Margaret Harris3, Jason Kennedy5, Laura Pemberton3, Gareth Price4, Hamid Sheikh3, David Woolf4, Joanna Coote3, Ahmed Salem6.   

Abstract

Outcomes of non-small cell lung cancer (NSCLC) patients with chronic obstructive pulmonary disease (COPD n = 587) and interstitial lung disease (ILD n = 34) treated with curative-intent radiotherapy were retrospectively investigated. Presence of ILD but not decreased forced expiratory volume in 1-second correlated with poor overall survival. Increased breathlessness and oxygen requirements after radiotherapy were observed in severe/very severe COPD and ILD.
Copyright © 2021 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  COPD; FEV1; ILD; NSCLC; Radiotherapy; Survival

Year:  2021        PMID: 33901563     DOI: 10.1016/j.radonc.2021.04.014

Source DB:  PubMed          Journal:  Radiother Oncol        ISSN: 0167-8140            Impact factor:   6.280


  3 in total

1.  β-Caryophyllene from Chilli Pepper Inhibits the Proliferation of Non-Small Cell Lung Cancer Cells by Affecting miR-659-3p-Targeted Sphingosine Kinase 1 (SphK1).

Authors:  Jiaji Lei; Qiushi Wang; Guanghua Li; Yongchao Li; Pengfei Zhang; Guangquan Xu
Journal:  Int J Gen Med       Date:  2021-12-10

Review 2.  Radiation-induced lung injury - what do we know in the era of modern radiotherapy?

Authors:  Marek Konkol; Paweł Śniatała; Piotr Milecki
Journal:  Rep Pract Oncol Radiother       Date:  2022-07-29

3.  The Effect of Teach-Back Combined with King Interactive Standard Mode on the Life of COPD Patients.

Authors:  Jiaxi Rang; Liming Peng; Long Wen; Zhiguo Zhou; You Xia; Chaoying Xie; Ting Xie; Jing Tan
Journal:  Contrast Media Mol Imaging       Date:  2022-09-20       Impact factor: 3.009

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.